Effect of lacidipine pre-treatment on diabetic neuropathy in rats
- PMID: 21091185
- DOI: 10.3109/13813455.2010.525241
Effect of lacidipine pre-treatment on diabetic neuropathy in rats
Abstract
Objective: The present study was planned to evaluate the effects of lacidipine on STZ induced diabetic neuropathy.
Material and methods: Streptozotocin (STZ) induced diabetic neuropathy in rats was monitored by measuring blood sugar levels, motor nerve conduction velocity (MNCV), nociception and histopathology of tibial nerve. Forty rats were divided in to four groups of 10 each. Group I: Control (vehicle). Group II: STZ (50mg/kg, iv, single injection). Group III: Lacidipine (0.5 mg/kg, po, daily + STZ). Group IV: STZ + insulin (4 unit/kg, sc, bid). Similar protocol was used for other parameters also.
Results: Lacidipine pre-treatment failed to reduce blood sugar levels in diabetic rats but prevented deterioration of motor nerve conduction velocity as compared to STZ diabetic rats. Hyperalgesia induced by STZ was antagonized by lacidipine. Histology of nerve showed less structural damage in lacidipine pre-treated group.
Discussion and conclusion: Thus, lacidipine prevents the development of neuropathic changes induced by STZ in rats.
Similar articles
-
Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats.Methods Find Exp Clin Pharmacol. 2001 Apr;23(3):131-4. doi: 10.1358/mf.2001.23.3.627945. Methods Find Exp Clin Pharmacol. 2001. PMID: 11523311
-
A comparison of the effects of conventional insulin treatment and continuous insulin infusion therapy on established morphological and biochemical abnormalities of peripheral nerve in experimental diabetes.Diabetes Res. 1990 Nov;15(3):143-50. Diabetes Res. 1990. PMID: 2132208
-
Novel protein kinase C-beta isoform selective inhibitor JTT-010 ameliorates both hyper- and hypoalgesia in streptozotocin- induced diabetic rats.Diabetes Obes Metab. 2005 Sep;7(5):586-94. doi: 10.1111/j.1463-1326.2004.00447.x. Diabetes Obes Metab. 2005. PMID: 16050952
-
The axonopathy of diabetic neuropathy.Diabetes. 1982 Apr;31(4 Pt 1):356-63. doi: 10.2337/diab.31.4.356. Diabetes. 1982. PMID: 6759251 Review. No abstract available.
-
Alternatives to the Streptozotocin-Diabetic Rodent.Int Rev Neurobiol. 2016;127:89-112. doi: 10.1016/bs.irn.2016.03.002. Epub 2016 Mar 28. Int Rev Neurobiol. 2016. PMID: 27133146 Free PMC article. Review.
Cited by
-
Lacidipine Prevents Scopolamine-Induced Memory Impairment by Reducing Brain Oxido-nitrosative Stress in Mice.Neurotox Res. 2021 Aug;39(4):1087-1102. doi: 10.1007/s12640-021-00346-w. Epub 2021 Mar 15. Neurotox Res. 2021. PMID: 33721210
-
Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling.Arch Pharm Res. 2022 Jul;45(7):475-493. doi: 10.1007/s12272-022-01391-5. Epub 2022 Jun 29. Arch Pharm Res. 2022. PMID: 35767208 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
